Effect of Met66 allele of the BDNF rs6265 SNP on regional gray matter volumes in patients with multiple sclerosis: A voxel-based morphometry study.

[1]  Leanne M Williams,et al.  Brain derived neurotrophic factor Val66Met polymorphism, the five factor model of personality and hippocampal volume: Implications for depressive illness , 2009, Human brain mapping.

[2]  F. Fera,et al.  A longitudinal observation of Brain-Derived Neurotrophic Factor mRNA levels in patients with Relapsing–Remitting Multiple Sclerosis , 2009, Brain Research.

[3]  Stephen M. Smith,et al.  Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference , 2009, NeuroImage.

[4]  F. Gianfagna,et al.  Meta-Analysis of the Brain-Derived Neurotrophic Factor Gene (BDNF) Val66Met Polymorphism in Anxiety Disorders and Anxiety-Related Personality Traits , 2008, Neuropsychobiology.

[5]  F. Holsboer,et al.  Variant form of STAT4 is associated with primary Sjögren's syndrome , 2008, Genes and Immunity.

[6]  G. Ebers.  Environmental factors and multiple sclerosis , 2008, The Lancet Neurology.

[7]  M. Ramanathan,et al.  Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor. , 2007, Human molecular genetics.

[8]  M J Wright,et al.  Effect of the BDNF V166M polymorphism on working memory in healthy adolescents , 2007, Genes, brain, and behavior.

[9]  F. Fera,et al.  Investigating the role of brain‐derived neurotrophic factor in relapsing–remitting multiple sclerosis , 2007, Genes, brain, and behavior.

[10]  P. Calabresi,et al.  Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-β 1a, and high doses of immunoglobulins , 2007, Multiple sclerosis.

[11]  Alan C. Evans,et al.  Focal cortical atrophy in multiple sclerosis: Relation to lesion load and disability , 2007, NeuroImage.

[12]  Josep M. Canals,et al.  Mutant huntingtin Impairs the Post-Golgi Trafficking of Brain-Derived Neurotrophic Factor But Not Its Val66Met Polymorphism , 2006, The Journal of Neuroscience.

[13]  Hans Lassmann,et al.  Remyelination is extensive in a subset of multiple sclerosis patients. , 2006, Brain : a journal of neurology.

[14]  Margit Burmeister,et al.  BDNF Val66Met Allele Is Associated with Reduced Hippocampal Volume in Healthy Subjects , 2006, Biological Psychiatry.

[15]  I. Deary,et al.  The brain-derived neurotrophic factor Val66Met polymorphism is associated with age-related change in reasoning skills , 2006, Molecular Psychiatry.

[16]  P. Lipsky,et al.  The Met66 allele of the functional Val66Met polymorphism in the brain-derived neurotrophic factor gene confers protection against neurocognitive dysfunction in systemic lupus erythematosus , 2006, Annals of the rheumatic diseases.

[17]  J. Yagüe,et al.  No association of the Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) to multiple sclerosis , 2006, Neuroscience Letters.

[18]  Bruno Alfano,et al.  Grey matter loss in relapsing–remitting multiple sclerosis: A voxel-based morphometry study , 2006, NeuroImage.

[19]  G. Kirov,et al.  Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder , 2006, British Journal of Psychiatry.

[20]  Wolfgang Brück,et al.  The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage , 2005, Journal of Neurology.

[21]  A. Karni,et al.  Lower brain-derived neurotrophic factor in serum of relapsing remitting MS: Reversal by glatiramer acetate , 2005, Journal of Neuroimmunology.

[22]  M. Ban,et al.  The BDNF-Val66Met polymorphism: Implications for susceptibility to multiple sclerosis and severity of disease , 2005, Journal of Neuroimmunology.

[23]  D Robinson,et al.  Brain-derived neurotrophic factor Val66met polymorphism and volume of the hippocampal formation , 2005, Molecular Psychiatry.

[24]  T. Robbins,et al.  The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson’s disease , 2005, Journal of Neurology.

[25]  A. Meyer-Lindenberg,et al.  The Brain-derived Neurotrophic Factor Val66met Polymorphism and Variation in Human Cortical Morphology , 2022 .

[26]  Petti T. Pang,et al.  Regulation of late-phase LTP and long-term memory in normal and aging hippocampus: role of secreted proteins tPA and BDNF , 2004, Ageing Research Reviews.

[27]  U. C. Wieshmann,et al.  Comparison of standard and optimized voxel-based morphometry for analysis of brain changes associated with temporal lobe epilepsy , 2004, NeuroImage.

[28]  A. Dale,et al.  Thinning of the cerebral cortex in aging. , 2004, Cerebral cortex.

[29]  Thomas E. Nichols,et al.  Nonstationary cluster-size inference with random field and permutation methods , 2004, NeuroImage.

[30]  J. Gorski,et al.  Early Striatal Dendrite Deficits followed by Neuron Loss with Advanced Age in the Absence of Anterograde Cortical Brain-Derived Neurotrophic Factor , 2004, The Journal of Neuroscience.

[31]  C. Sommer,et al.  Effect of Brain-Derived Neurotrophic Factor Treatment and Forced Arm Use on Functional Motor Recovery After Small Cortical Ischemia , 2004, Stroke.

[32]  M. Stangel.  Remyelinating and neuroprotective treatments in multiple sclerosis , 2004, Expert opinion on investigational drugs.

[33]  M. Egan,et al.  Brain-Derived Neurotrophic Factor val66met Polymorphism Affects Human Memory-Related Hippocampal Activity and Predicts Memory Performance , 2003, The Journal of Neuroscience.

[34]  Bai Lu,et al.  BDNF and activity-dependent synaptic modulation. , 2003, Learning & memory.

[35]  M. Egan,et al.  The BDNF val66met Polymorphism Affects Activity-Dependent Secretion of BDNF and Human Memory and Hippocampal Function , 2003, Cell.

[36]  V. Gallai†,et al.  Brain-derived neurotrophic factor in patients with multiple sclerosis , 2002, Journal of Neuroimmunology.

[37]  Robin J. M. Franklin,et al.  Why does remyelination fail in multiple sclerosis? , 2002, Nature Reviews Neuroscience.

[38]  B. Weinshenker,et al.  Identifying disease modifying genes in multiple sclerosis , 2002, Journal of Neuroimmunology.

[39]  R. Rudick,et al.  Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. , 2002, The New England journal of medicine.

[40]  Thomas E. Nichols,et al.  Nonparametric permutation tests for functional neuroimaging: A primer with examples , 2002, Human brain mapping.

[41]  Barbara L. Hempstead,et al.  Regulation of Cell Survival by Secreted Proneurotrophins , 2001, Science.

[42]  R. Rudick,et al.  Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS , 2001, Neurology.

[43]  L. Krupp,et al.  Cognitive Dysfunction Lateralizes With NAA in Multiple Sclerosis , 2001, Applied neuropsychology.

[44]  Karl J. Friston,et al.  A Voxel-Based Morphometric Study of Ageing in 465 Normal Adult Human Brains , 2001, NeuroImage.

[45]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[46]  Markus Schwaninger,et al.  Intravenous Brain-Derived Neurotrophic Factor Reduces Infarct Size and Counterregulates Bax and Bcl-2 Expression After Temporary Focal Cerebral Ischemia , 2000, Stroke.

[47]  J L Lancaster,et al.  Automated Talairach Atlas labels for functional brain mapping , 2000, Human brain mapping.

[48]  Karl J. Friston,et al.  Voxel-Based Morphometry—The Methods , 2000, NeuroImage.

[49]  Tobias Bonhoeffer,et al.  Essential Role for TrkB Receptors in Hippocampus-Mediated Learning , 1999, Neuron.

[50]  L. Zhang,et al.  Impairments in High-Frequency Transmission, Synaptic Vesicle Docking, and Synaptic Protein Distribution in the Hippocampus of BDNF Knockout Mice , 1999, The Journal of Neuroscience.

[51]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[52]  J. Ashburner,et al.  Multimodal Image Coregistration and Partitioning—A Unified Framework , 1997, NeuroImage.

[53]  J. Conner,et al.  Distribution of Brain-Derived Neurotrophic Factor (BDNF) Protein and mRNA in the Normal Adult Rat CNS: Evidence for Anterograde Axonal Transport , 1997, The Journal of Neuroscience.

[54]  C. Altar,et al.  Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[55]  R. Lindsay,et al.  The Neurotrophins NT-4/5 and BDNF Augment Serotonin, Dopamine, and GABAergic Systems during Behaviorally Effective Infusions to the Substantia Nigra , 1994, Experimental Neurology.

[56]  F. Fazio,et al.  Relationship between corpus callosum atrophy and cerebral metabolic asymmetries in multiple sclerosis , 1992, Journal of the Neurological Sciences.

[57]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[58]  Mu-ming Poo,et al.  Neurotrophins as synaptic modulators , 2001, Nature Reviews Neuroscience.